US Stock MarketDetailed Quotes

PLXPQ PLx Pharma

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose Oct 2 16:00 ET
29.14Market Cap0.00P/E (TTM)

About PLx Pharma Company

PLx Pharma Winddown Corp Formerly PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. It believes this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach erosions and ulcers associated with drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.

Company Profile

SymbolPLXPQ
Company NamePLx Pharma
CEOMs. Natasha Giordano
MarketPink Market
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Natasha Giordano
  • Director, President and Chief Executive Officer
  • --
  • Lawrence R. Perkins
  • Chief Restructuring Officer
  • --
  • John Halloran
  • Deputy Chief Restructuring Officer
  • --
  • Rita M. O'Connor
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Michael J. Valentino
  • Non-Executive Chairman of the Board
  • --
  • Kirk K. Calhoun
  • Independent Director
  • --
  • Gary S. Balkema
  • Independent Director
  • --
  • Robert Casale
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg